Three down, two to go when it comes to major regulatory hurdles that Medtronic and Covidien need to clear for their proposed $43 billion merger. The U.S. Federal Trade Commission, the European Union and Canada’s Competition Bureau ...
German medical device company Biotronik has launched its Passeo-35 0.035” OTW PTA balloon line extension and the Passeo-35 HP 0.035” high pressure PTA (percutaneous transluminal angioplasty) balloon. Available in lengths of up ...
Tags: Biotronik, Balloon Line Extension
Medtronic has received both the US Food and Drug Administration (FDA) approval and the CE (Conformité Européenne) Mark clearance for its Pacific Plus percutaneous transluminal angioplasty (PTA), the new peripheral balloon ...
Tags: Angioplasty Balloon, Medicine
Medtronic has completed patient enrollment in controlled, multicenter, prospective IN.PACT SFA II clinical trial of its IN.PACT Admiral drug-eluting balloon device for treating patients with peripheral artery disease in the superficial ...
Tags: drug, Medtronic, eluting balloon study
C. R. Bard's Lutonix technology center has completed enrolling patients in its pivotal investigational device exemption (IDE) LEVANT 2 trial, designed to evaluate Lutonix drug coated PTA dilatation catheter (DCB) as a treatment for ...
Tags: pivotal investigational device, drug coated PTA dilatation catheter